New research reveals how serum soluble Klotho levels relate to chronic kidney disease risk (CKD) in patients with diabetes ...

New research disentangles the risks for acute kidney injury related to CAR T-cell treatment in non-Hodgkin lymphoma, ...

Puma Biotechnology release its 1Q'25 earnings results on May 8 after markets closed and followed with a conference call to ...

Janux Therapeutics, Inc. (Nasdaq: JANX) (Janux), a clinical-stage biopharmaceutical company developing a broad pipeline of ...

Discover the critical indicators medical professionals use to detect kidney damage early, from blood tests and urine analysis ...

DISCLAIMER: This site and the products offered are for entertainment purposes only, and there is no gambling offered on this site. This service is intended for adult audiences. No guarantees are made ...

The FDA is reviewing the BLA for clesrovimab to prevent respiratory syncytial virus (RSV) disease in infants during their first RSV season. Clesrovimab is an extended half-life RSV fusion glycoprotein ...

The Fund seeks to provide returns consistent with the performance of the Index. Important notice: This product is based overseas and is not subject to UK sustainable investment labelling and ...

Over my forty years or so in and around dealing rooms and financial markets, I have heard many theories as to how to approach that problem and have settled on a process that has worked for me.

The prevalence of LEs for level 1 survivors was 11.6% with only one patient with grade 3 or above toxicity ... 5 died from second primary malignancy and 1 from end-stage renal failure. Of the five ...